• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浅析阿尔茨海默病中的 TAM 系统。

An insight into the TAM system in Alzheimer's disease.

机构信息

State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

出版信息

Int Immunopharmacol. 2023 Mar;116:109791. doi: 10.1016/j.intimp.2023.109791. Epub 2023 Feb 2.

DOI:10.1016/j.intimp.2023.109791
PMID:36738678
Abstract

The TAM receptors may help delay the progression of Alzheimer's disease (AD). AD is the most common neurodegenerative disease associated with human aging. The TAM receptors, derived from the first letter of its three constituents -Tyro3, Axl, and Mertk, are associated with immune responses, cellular differentiation and migration, and clearance of apoptotic cells and debris, with the two canonical ligands, Growth Arrest Specific 6 (Gas6) and ProS1. Several kinds of research have indicated the participation of the TAM system in AD pathology. Also, the TAMs regulate multiple features of microglia, the significant sensors of disorder in the central nervous system (CNS). In this review, we describe the biology of the TAM receptors and ligands in the CNS. Then, we discuss the relationship between the TAM system and AD, specially focusing on its functional expression in the microglia. Finally, we also summarize some agents that could interfere with the TAM signaling pathways and discuss potential difficulties and strategies for drug development.

摘要

TAM 受体可能有助于延缓阿尔茨海默病(AD)的进展。AD 是最常见的与人类衰老相关的神经退行性疾病。TAM 受体来源于其三个组成部分(Tyro3、Axl 和 Mertk)的首字母,与免疫反应、细胞分化和迁移以及凋亡细胞和碎片的清除有关,其两个典型配体为生长停滞特异性 6(Gas6)和 ProS1。许多研究表明 TAM 系统参与了 AD 病理学。此外,TAMs 调节小胶质细胞的多种特征,小胶质细胞是中枢神经系统(CNS)紊乱的重要传感器。在这篇综述中,我们描述了 TAM 受体和配体在中枢神经系统中的生物学特性。然后,我们讨论了 TAM 系统与 AD 的关系,特别是其在小胶质细胞中的功能表达。最后,我们还总结了一些可能干扰 TAM 信号通路的药物,并讨论了药物开发的潜在困难和策略。

相似文献

1
An insight into the TAM system in Alzheimer's disease.浅析阿尔茨海默病中的 TAM 系统。
Int Immunopharmacol. 2023 Mar;116:109791. doi: 10.1016/j.intimp.2023.109791. Epub 2023 Feb 2.
2
TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration.TAM 受体途径在神经炎症和神经变性的十字路口。
Dis Markers. 2019 Sep 15;2019:2387614. doi: 10.1155/2019/2387614. eCollection 2019.
3
The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.TAM 家族受体及其配体在神经系统中的作用:从发育到病理生物学。
Pharmacol Ther. 2018 Aug;188:97-117. doi: 10.1016/j.pharmthera.2018.03.002. Epub 2018 Mar 4.
4
Dysregulation of TLR5 and TAM Ligands in the Alzheimer's Brain as Contributors to Disease Progression.TLR5 和 TAM 配体在阿尔茨海默病大脑中的失调是疾病进展的原因之一。
Mol Neurobiol. 2019 Sep;56(9):6539-6550. doi: 10.1007/s12035-019-1540-3. Epub 2019 Mar 9.
5
TAM receptor signaling in immune homeostasis.免疫稳态中的TAM受体信号传导。
Annu Rev Immunol. 2015;33:355-91. doi: 10.1146/annurev-immunol-032414-112103. Epub 2015 Jan 14.
6
Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.受体酪氨酸激酶TYRO3、AXL和MER表现出不同的模式以及配体诱导激活的复杂调控。
J Biol Chem. 2014 Sep 12;289(37):25750-63. doi: 10.1074/jbc.M114.569020. Epub 2014 Jul 29.
7
TAM receptors in phagocytosis: Beyond the mere internalization of particles.吞噬作用中的 TAM 受体:超越颗粒的单纯内化。
Immunol Rev. 2023 Oct;319(1):7-26. doi: 10.1111/imr.13267. Epub 2023 Aug 19.
8
Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells.半乳糖凝集素-3 可刺激酪氨酸 3 受体酪氨酸激酶和 Erk 信号转导、细胞存活和人类癌细胞迁移。
Biomolecules. 2020 Jul 11;10(7):1035. doi: 10.3390/biom10071035.
9
Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6.生长停滞特异性蛋白6激活Tyro3、Axl和Mertk受体对γ-羧基谷氨酸修饰及磷脂酰丝氨酸结合的需求
Front Immunol. 2017 Nov 10;8:1521. doi: 10.3389/fimmu.2017.01521. eCollection 2017.
10
Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure.Gas6 和 Axl 信号的缺失会导致广泛的轴突损伤、运动功能障碍、神经炎症持续时间延长,以及在受到铜锌卟啉(一种多发性硬化症动物模型)暴露后少突胶质细胞的髓鞘再生减少。
Glia. 2017 Dec;65(12):2051-2069. doi: 10.1002/glia.23214. Epub 2017 Sep 19.

引用本文的文献

1
Locus coeruleus integrity correlates with plasma soluble Axl levels in Alzheimer's disease patients.在阿尔茨海默病患者中,蓝斑核完整性与血浆可溶性Axl水平相关。
Alzheimers Dement. 2025 Jul;21(7):e70434. doi: 10.1002/alz.70434.
2
The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI.FGFR抑制剂Rogaratinib可降低创伤性脑损伤中的小胶质细胞反应性和突触损失。
Front Immunol. 2024 Nov 20;15:1443940. doi: 10.3389/fimmu.2024.1443940. eCollection 2024.
3
Long Non-Coding RNAs and Alzheimer's Disease: Towards Personalized Diagnosis.
长非编码 RNA 与阿尔茨海默病:迈向个体化诊断。
Int J Mol Sci. 2024 Jul 11;25(14):7641. doi: 10.3390/ijms25147641.
4
Targeting Microglia in Alzheimer's Disease: Pathogenesis and Potential Therapeutic Strategies.靶向阿尔茨海默病中的小胶质细胞:发病机制与潜在治疗策略。
Biomolecules. 2024 Jul 11;14(7):833. doi: 10.3390/biom14070833.
5
Novel Therapeutic Strategies in Alzheimer's Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond.阿尔茨海默病的新型治疗策略:抗淀粉样蛋白疗法及其他疗法的陷阱与挑战
J Clin Med. 2024 May 25;13(11):3098. doi: 10.3390/jcm13113098.
6
Patient-derived induced pluripotent stem cells with a mutation exhibit cell junction abnormalities and aberrant cellular differentiation potential.携带突变的患者来源的诱导多能干细胞表现出细胞连接异常和异常的细胞分化潜能。
World J Stem Cells. 2024 May 26;16(5):512-524. doi: 10.4252/wjsc.v16.i5.512.
7
Biofluid biomarkers for Alzheimer's disease.用于阿尔茨海默病的生物流体生物标志物。
Front Aging Neurosci. 2024 Apr 10;16:1380237. doi: 10.3389/fnagi.2024.1380237. eCollection 2024.